7LAB (1021.206.793): financials and annual accounts

7LAB

Ixelles ·KBO/BCE: BE 1021.206.793

Line	Trend	2025
Balance sheet: assets
Total assets`20/58`		58,820
Current assets`29/58`		58,820
Amounts receivable within one year`40/41`		14,581
Trade receivables`40`		12,100
Other amounts receivable`41`		2,481
Cash at bank and in hand`54/58`		44,140
Deferred charges and accrued income`490/1`		99
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`		58,820
Equity`10/15`		41,440
Contributions`10/11`		3,500
Profit (loss) carried forward`14`		37,940
Amounts payable`17/49`		17,380
Amounts payable within one year`42/48`		17,380
Trade debts`44`		28
Suppliers`440/4`		28
Taxes, remuneration and social security`45`		17,352
Taxes`450/3`		16,052
Remuneration and social security`454/9`		1,300
Income statement
Gross operating margin`9900`		47,628
Operating profit (loss)`9901`		47,628
Financial income`75/76B`		73
Recurring financial income`75`		73
Financial charges`65/66B`		0
Recurring financial charges`65`		0
Profit (loss) for the period before taxes`9903`		47,701
Income taxes`67/77`		9,761
Profit (loss) for the period`9904`		37,940
Profit (loss) for the period to be appropriated`9905`		37,940
Appropriation of the result
Profit (loss) to be appropriated`9906`		37,940
Document		PDF

7LAB